Sarepta Therapeutics, Inc. - Significant Ownership

Signature - Title
Sarepta Therapeutics, Inc. - Ian Estepan, Executive Vice President, Chief Financial Officer
Location
Cambridge, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sarepta Therapeutics, Inc..

Significant Ownership of Sarepta Therapeutics, Inc.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARWR ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock") 9.5% $180M 11.9M Sarepta Therapeutics, Inc. Feb 7, 2025

Schedules 13D/G Reported by Sarepta Therapeutics, Inc.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.